The Detection of Vaccine Virus and Protection of a Modified Live, Intranasal, Trivalent Vaccine in Neonatal, Colostrum-Fed Calves with an Experimental Bovine Respiratory Syncytial Virus Challenge
Pathogens · 2024
DOI: 10.3390/pathogens13060517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Stephanie Perkins-Oines und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinvet-South Dakota, 801 32nd Ave, Brookings, SD 57006, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Bovine, Colostrum, Administration, Intranasal. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck Animal Health.
Abstract (Originalsprache)
The efficacy of an intranasal (IN) bovine respiratory syncytial virus (BRSV) vaccine administered in the presence of passive immunity was assessed. Pooled colostrum was administered by intubation to 50 beef-dairy crossbred calves the day they were born. The calves were transported to a research facility and were blocked by age and sex, and randomly assigned into two groups: sham-vaccinated intranasally with a placebo (sterile water) or vaccinated with a trivalent (BRSV, bovine herpesvirus 1 and bovine parainfluenza 3) modified live viral (MLV) vaccine. The calves were 9 ± 2 days old when vaccinated (day 0). The calves were challenged by aerosolized BRSV on days 80 and 81 as a respiratory challenge. The study was terminated on day 88. Lung lesion scores (LLS) were significantly lower for calves vaccinated with trivalent MLV vaccine than those for calves that were sham-vaccinated. Serum neutralization (SN) antibody against BRSV in calves vaccinated with the trivalent MLV vaccine demonstrated an anamnestic response on day 88. After challenge, the calves sham-vaccinated with the placebo lost weight, while those vaccinated with the trivalent MLV vaccine gained weight. In this study, colostrum-derived antibodies did not interfere with the immune response or protection provided by one dose of the trivalent MLV vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinvet-South Dakota, 801 32nd Ave, Brookings, SD 57006, USA.
- Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.
- Beef Technical Services, Merck Animal Health, DeSoto, KS 66018, USA.
- Department of Veterinary and Biomedical Sciences, College of Agriculture, Food and Environmental Sciences, South Dakota State University, Brookings, SD 57007, USA.
ORCID-Profile: Karim Abdelsalam, Christopher C L Chase
Förderung
- Merck Animal Health
Zitieren
APA
Perkins-Oines, S., Senevirathne, N. D., Krafsur, G. M., Abdelsalam, K., Renter, D., Meyer, B., & Chase, C. C. L. (2024). The Detection of Vaccine Virus and Protection of a Modified Live, Intranasal, Trivalent Vaccine in Neonatal, Colostrum-Fed Calves with an Experimental Bovine Respiratory Syncytial Virus Challenge. Pathogens. https://doi.org/10.3390/pathogens13060517
Vancouver
Perkins-Oines S, Senevirathne ND, Krafsur GM, Abdelsalam K, Renter D, Meyer B, et al. The Detection of Vaccine Virus and Protection of a Modified Live, Intranasal, Trivalent Vaccine in Neonatal, Colostrum-Fed Calves with an Experimental Bovine Respiratory Syncytial Virus Challenge. Pathogens. 2024. doi:10.3390/pathogens13060517
BibTeX
@article{PerkinsOines2024,
author = {Perkins-Oines, Stephanie and Senevirathne, Nirosh D and Krafsur, Greta M and Abdelsalam, Karim and Renter, David and Meyer, Brent and Chase, Christopher C L},
title = {The Detection of Vaccine Virus and Protection of a Modified Live, Intranasal, Trivalent Vaccine in Neonatal, Colostrum-Fed Calves with an Experimental Bovine Respiratory Syncytial Virus Challenge},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13060517}
}
EUVIMED